AxoGen, Inc.
AXGN
$9.73
$0.444.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.71% | 1.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.71% | 1.56% | |||
| Cost of Revenue | 15.19% | -3.08% | |||
| Gross Profit | -7.03% | 3.12% | |||
| SG&A Expenses | 5.71% | -3.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.98% | -3.21% | |||
| Operating Income | -182.35% | 738.29% | |||
| Income Before Tax | -952.00% | 124.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -952.00% | 124.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -952.00% | 124.22% | |||
| EBIT | -182.35% | 738.29% | |||
| EBITDA | -96.40% | 165.19% | |||
| EPS Basic | -948.00% | 123.64% | |||
| Normalized Basic EPS | -941.27% | 123.77% | |||
| EPS Diluted | -948.00% | 123.64% | |||
| Normalized Diluted EPS | -998.31% | 122.26% | |||
| Average Basic Shares Outstanding | 0.73% | 2.27% | |||
| Average Diluted Shares Outstanding | -5.95% | 9.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||